Weir MR, McCullough PA, Buse JB, Anderson J, et al. Renal and Cardiovascular Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: Perspectives on the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Am J Nephrol 2020 Mar 13:1-13. doi: 10.1159/000506533.
PMID: 32172239